An investigator-initiated registration-directed phase I/II clinical trial of irinotecan hydrochroride for refractory pediatric solid tumors. Background: Cilengitide is a selective αvβ3/αvβ5 integrin ...
Pharmacokinetics (PK) of split-dose flavopiridol (F) administered with CPT-11 (CPT) and cisplatin (Cis) No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results